Trial Profile
Predictors of trastuzumab use in early-stage breast cancer: SEER-Medicare database study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 25 Apr 2016
Price :
$35
*
At a glance
- Drugs Trastuzumab (Primary)
- Indications Breast cancer
- Focus Therapeutic Use
- 25 Apr 2016 New trial record
- 11 Apr 2016 Results published in the Journal of Clinical Oncology